Zestmab 500mg Injection
Marketer
RPG Life Sciences Ltd
Salt Composition
Rituximab (500mg)
Overview Zestmab 500mg Injection
In patients with non-Hodgkin's lymphoma (NHL), rheumatoid arthritis, chronic lymphocytic leukemia (CLL), granulomatosis with polyangiitis, and microscopic polyangiitis, Zestmab 500mg Injection offers therapeutic benefits. Administered intravenously under medical supervision, the dosage and frequency are determined by the treating physician, tailored to the specific condition and subject to adjustment. Strict adherence to the prescribed regimen is crucial; improper usage or overdose may result in severe adverse reactions. While therapeutic effects might not be immediately apparent, requiring weeks or months, discontinuation should only occur under medical guidance. Commonly reported side effects include headache, fatigue, swelling, infections, and alopecia. This medication can lower blood cell counts, raising infection risk, necessitating routine blood tests, including hepatitis B monitoring. Prior to commencement, disclosure of pre-existing heart or liver conditions, planned surgical procedures or immunizations, and all concurrent medications is mandatory. Interactions with other drugs are possible, demanding comprehensive medication disclosure. Use during pregnancy or lactation is discouraged, and effective contraception is vital for both partners throughout the treatment period.
Uses of Zestmab 500mg Injection
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin's lymphoma.
Major Benefits of Zestmab 500mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Zestmab 500mg Injection:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Zestmab 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Zestmab 500mg Injection works:
In rheumatoid arthritis and specific cancers, the monoclonal antibody Zestmab 500mg Injection neutralizes the aberrant function of B lymphocytes, a type of immune cell.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Zestmab 500mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Zestmab 500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is recommended.
Breast feedingSAFE IF PRESCRIBED
The administration of Zestmab 500mg Injection while breastfeeding appears to pose minimal risk. Available human data indicate a low likelihood of harm to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Zestmab 500mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Use of the 500mg Zestmab injection in patients with kidney disease appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Zestmab 500mg Injection's application in individuals with hepatic impairment. Physician consultation is advised. Zestmab 500mg Injection is contraindicated for patients experiencing active liver disease or a history of viral hepatitis due to the potential for infection recurrence.
What if you forget to take Zestmab 500mg Injection :
Should you forget a scheduled Zestmab 500mg Injection, seek your physician's advice.
Facts to Know About Zestmab 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | CD20-targeting agent |
3,018 People bought this recently